LU45106A1 - - Google Patents
Info
- Publication number
- LU45106A1 LU45106A1 LU45106DA LU45106A1 LU 45106 A1 LU45106 A1 LU 45106A1 LU 45106D A LU45106D A LU 45106DA LU 45106 A1 LU45106 A1 LU 45106A1
- Authority
- LU
- Luxembourg
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5790262 | 1962-12-27 | ||
| JP5741963 | 1963-10-29 | ||
| JP6427663 | 1963-10-29 | ||
| JP6250163 | 1963-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU45106A1 true LU45106A1 (en) | 1964-02-24 |
Family
ID=27463499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU45106D LU45106A1 (en) | 1962-12-27 | 1963-12-23 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE641880A (en) |
| FR (1) | FR3150M (en) |
| GB (1) | GB1080599A (en) |
| LU (1) | LU45106A1 (en) |
| NL (1) | NL302572A (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2495608A1 (en) * | 1980-12-04 | 1982-06-11 | Morelle Jean | NEW ASPARTIC ACID DERIVATIVES AND THEIR USES |
| DK1824563T3 (en) | 2004-11-26 | 2010-05-31 | Ucl Business Plc | Compositions comprising ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy |
| LT3686183T (en) | 2009-04-03 | 2022-11-10 | Ocera Therapeutics, Inc. | L-ornithine phenyl acetate and methods of making thereof |
| WO2010144498A2 (en) | 2009-06-08 | 2010-12-16 | Ucl Business Plc | Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
| CN103502203B (en) | 2010-10-06 | 2016-09-07 | 欧塞拉治疗有限公司 | The method preparing L-Orn phenyl acetate salt |
| AU2015353703B2 (en) | 2014-11-24 | 2021-04-01 | Ucl Business Plc | Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies |
| CA2995823A1 (en) | 2015-08-18 | 2017-02-23 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
| US11066352B2 (en) | 2017-05-11 | 2021-07-20 | Ocera Therapeutics, Inc. | Processes of making L-ornithine phenylacetate |
| CN107540413A (en) * | 2017-09-14 | 2018-01-05 | 精晶药业股份有限公司 | A kind of method that urea is extracted in the crystalline mother solution from aspartic acid ornithine |
-
0
- NL NL302572D patent/NL302572A/xx unknown
-
1963
- 1963-12-23 LU LU45106D patent/LU45106A1/xx unknown
- 1963-12-23 GB GB50695/63A patent/GB1080599A/en not_active Expired
- 1963-12-26 FR FR958559A patent/FR3150M/en active Active
- 1963-12-27 BE BE641880A patent/BE641880A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR3150M (en) | 1965-02-22 |
| BE641880A (en) | 1964-04-16 |
| GB1080599A (en) | 1967-08-23 |
| NL302572A (en) |